Dacarbazine is an anti-cancer drug used to treat Hodgkin's lymphoma and malignant melanoma. However, it may contain impurities that can affect its quality and safety. These impurities may include related substances, residual solvents, and inorganic impurities. Therefore, it's essential to identify and control these impurities to ensure the effectiveness and safety of the drug.
